Track topics on Twitter Track topics that are important to you
Cannabics Pharmaceuticals Inc (OTCQB:CNBX) CEO and Co-Founder Dr. Eyal Barad spoke with Proactive Investors at the ThinkEquity Conference in New York. The Israeli-based company is developing a platform that leverages drug-screening tools and artificial intelligence to create cannabinoid-based therapies for cancer.
Original Article: Cannabics looking to the future and using cannabinoids to fight cancerNEXT ARTICLE
Pharmacy is the science and technique of preparing as well as dispensing drugs and medicines. It is a health profession that links health sciences with chemical sciences and aims to ensure the safe and effective use of pharmaceutical drugs. The scope of...
Bladder Cancer Brain Cancer Breast Cancer Cancer Cervical Cancer Colorectal Head & Neck Cancers Hodgkin Lymphoma Leukemia Lung Cancer Melanoma Myeloma Ovarian Cancer Pancreatic Cancer ...